Source: Virtual Congress 2021 – Back to infection basics



Rating:

Share or cite this content

Citations should be made in the following way:
D. Parr (Coventry (West Midlands), United Kingdom), C. Clarenbach (Zurich, Switzerland), J. Chorostowska-Wynimko (Warsaw, Poland), A. Corsico (Pavia, Italy), I. Ferrarotti (Pavia, Italy), L. Lázaro-Asegurado (Burgos, Spain), J. Lopez-Campos (Seville, Spain), A. Rozy (Warsaw, Poland), A. Sark (Leiden, Netherlands), M. Sucena (Porto, Portugal), J. Stolk (Leiden, Netherlands), E. Tabernero Huguet (Biocruces-Bizkaia, Spain), H. Tanash (Lund, Sweden), M. Miravitlles (Barcelona, Spain). Late Breaking Abstract - Impact of COVID-19 on patients with severe alpha1 antitrypsin deficiency: the IMCA1 study of the EARCO ERS Clinical Research Collaboration, preliminary findings.. 2365

Member's Comments

No comment yet.

Related content which might interest you: The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency Source: Eur Respir J, 53 (2) 1900138; 10.1183/13993003.00138-2019 Year: 2019 Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR) Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Late Breaking Abstract - NORdic Database for aSThmA Research (NORDSTAR): Swedish and Finnish patients Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018 Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR) Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 The Severe Paediatric Asthma Collaborative in Europe (SPACE) ERS Clinical Research Collaboration: enhancing participation of children with asthma in therapeutic trials of new biologics and receptor blockers Source: Eur Respir J, 52 (4) 1801665; 10.1183/13993003.01665-2018 Year: 2018 The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research Source: Eur Respir J, 52 (5) 1801671; 10.1183/13993003.01671-2018 Year: 2018 Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Preliminary results from the laboratory phase of ECRHSIII in Melbourne Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Late Breaking Abstract - Small Airways Dysfunction (SAD) correlates with relevant asthma outcomes: longitudinal results from the AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Study Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 The European Sleep Apnoea Database (ESADA) ERS Clinical Research Collaboration: past, present and future Source: Eur Respir J, 52 (4) 1801666; 10.1183/13993003.01666-2018 Year: 2018 Late Breaking Abstract - Implementation of universal valid methodology in the diagnosis of occupational asthma(Ege University Translational Pulmonology Research Group [EgeTPAG]) Source: International Congress 2017 – Case reports and series Year: 2017 Late Breaking Abstract - Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival. Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 ATS / ERS: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Source: Guideline 2003 Year: 2003 Impact of the British Lung Foundation Active Steps service on patient reported outcomes:  concurrent cohort study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study Source: ERJ Open Res, 8 (1) 00552-2021; 10.1183/23120541.00552-2021 Year: 2022 Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale Source: ERJ Open Res, 7 (3) 00201-2021; 10.1183/23120541.00201-2021 Year: 2021 Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey. Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019